Zurn Elkay director granted 607 ZWS shares
Longren David C. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Longren David C. reported acquisition or exercise transactions in this Form 4 filing.
Zurn Elkay Water Solutions director David C. Longren received 607 shares of Common Stock as a grant on April 15, 2026, at $47.39 per share. The shares represent payment of director fees in restricted stock units that vested immediately, with payout deferred until six months after his service as a director ends. Following this grant, he holds 98,217 shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 607 | $47.39 | $29K |
Footnotes (1)
- F1. Payment of director fees in restricted stock units, which vested immediately, but is not paid out until six months after the Reporting Person's cessation of service as a director.
Key Figures
Key Terms
restricted stock units financial
director fees financial
cessation of service financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Zurn Elkay Water Solutions (ZWS) director David C. Longren report?
What does the footnote about restricted stock units mean in the ZWS Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.